A detailed history of Asset Management Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Asset Management Group, Inc. holds 6,805 shares of MRK stock, worth $679,547. This represents 0.11% of its overall portfolio holdings.

Number of Shares
6,805
Previous 6,767 0.56%
Holding current value
$679,547
Previous $837,000 7.77%
% of portfolio
0.11%
Previous 0.13%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$111.15 - $128.97 $4,223 - $4,900
38 Added 0.56%
6,805 $772,000
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $30,578 - $32,841
247 Added 3.79%
6,767 $837,000
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $7,926 - $9,236
70 Added 1.09%
6,520 $860,000
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $26,146 - $28,454
-261 Reduced 3.89%
6,450 $703,000
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $4,220 - $4,687
41 Added 0.61%
6,711 $690,000
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $4,235 - $4,616
39 Added 0.59%
6,670 $769,000
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $4,014 - $4,479
39 Added 0.59%
6,631 $705,000
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $3,585 - $4,596
41 Added 0.63%
6,592 $731,000
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $77,260 - $86,793
914 Added 16.21%
6,551 $564,000
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $110,206 - $124,924
1,320 Added 30.58%
5,637 $514,000
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $2,352 - $2,636
32 Added 0.75%
4,317 $354,000
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $19,804 - $24,807
-274 Reduced 6.01%
4,285 $328,000
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $8,028 - $8,828
-112 Reduced 2.4%
4,559 $342,000
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $328,418 - $363,263
4,671 New
4,671 $363,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Asset Management Group, Inc. Portfolio

Follow Asset Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management Group, Inc. with notifications on news.